Skip to content
Home » News » UK firm GSK to pay $2.2bn over Zantac cancer claims

UK firm GSK to pay $2.2bn over Zantac cancer claims

The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants. Read More